Vineet Laboratories Limited (VINEETLAB.BO)

INR 59.9

(0.64%)

Market Cap (In INR)

552.21 Million

Revenue (In INR)

1.5 Billion

Net Income (In INR)

10.27 Million

Avg. Volume

14.55 Thousand

Currency
INR
Country
Basic Materials
Open
-
Prev. Close
-
Day Range
-
Year Range
46.98-88.95
PE
-
EPS
-
Beta Value
-0.28
ISIN
INE505Y01010
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Basic Materials
Industry
Chemicals
CEO
Mr. Gaddam Venkata Ramana
Employee Count
-
Website
https://vineetlabs.co.in
Ipo Date
Details
Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients and fine chemicals in India. It offers intermediates of lopinavir, ritonavir, efavirenz, nadolol, glimepiride, celecoxib, olanine, and other API intermediates; and fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside, 4-nitrophenyl phosphate disodium salt, 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside, 5-acetyl thiophene-2-carboxilic acid, 4-chlorobutyryl chloride, n-butyl magnesium chloride, 3-furaldehyde, 3-bromofuran, n-butylnitrite, ethyldiazo acetate, phenylboronic acid, 6-aminouracil, and 1-methyl-imidazole-2-carboxaldehyde. The company was incorporated in 2016 and is based in Hyderabad, India.